Krex Brian 4
4 · APPLIED GENETIC TECHNOLOGIES CORP · Filed Apr 18, 2019
Insider Transaction Report
Form 4
Krex Brian
General Counsel
Transactions
- Award
Stock Option (right to buy)
2019-03-25+125,000→ 125,000 totalExercise: $4.20Exp: 2029-03-25→ Common Stock (125,000 underlying)
Footnotes (1)
- [F1]Opton becomes exercisable for 25% of the underlying shares on the first anniversary of the grant date, and thereafter becomes exercisable for the remaining underlying shares, in equal monthly installments over three years, reuslting in the option being exercisable for 100% of the underlying shares on the fourth anniversary of the grant date.